scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Par Drugs & Chemicals Ltd

Feedback
Par Drugs & Chemicals Ltd

Par Drugs & Chemicals Ltd (PAR) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 28,757
Mar 13, 2025 15:51 IST-
  • NSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹97.74
₹-1.10 (-1.11%)
₹96.05 Low
Today’s Performance
₹102.7 High
₹89.7 Low
52 Week’s Performance
₹348.45 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -1.11%
  • 1 Week 0.16%
  • 1 Month -40.74%
  • 3 Months -56.16%
  • 6 Months -61.99%
  • 1 Year -51.84%
  • 3 Years -14.87%
  • 5 Years 40.27%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 10.00
  • Beta 1.01
  • 52-Week Low (₹) 89.70
  • 52-Week High (₹) 348.45
  • Price-to-Book (X)* 1.24
  • Dividend Yield (%) 0.00
  • Price-to-Earnings (P/E) (X)* 7.79
  • Earnings Per Share (₹) 12.54
  • Sector Price Earning (X)* 32.46
  • Market Cap (₹ Cr.)* 120.27
  • * Vaues as of last close price

COMPETITORS

BT TV

Navneet Munot: Short-Term Moves Are Unpredictable, But Long-Term Investors Will Gain 1:48 Navneet Munot: Short-Term Moves Are Unpredictable, But Long-Term Investors Will Gain
Jamie Dimon On Remote Work: Why WFH Doesn’t Work For JPMorgan 5:37 Jamie Dimon On Remote Work: Why WFH Doesn’t Work For JPMorgan
Investing In Adani Group: Expert Reveals The Most Promising Stock For Long-Term Growth 1:21 Investing In Adani Group: Expert Reveals The Most Promising Stock For Long-Term Growth
Top Expert Analyses The Potential Recessionary Impact Of US President Trump's Trade War 1:29 Top Expert Analyses The Potential Recessionary Impact Of US President Trump's Trade War
Inside Jagan Mohan's Rushikonda Palace: Luxury, Controversy & Unused Grandeur 5:24 Inside Jagan Mohan's Rushikonda Palace: Luxury, Controversy & Unused Grandeur
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE

No Data For Block Deal.

*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Jan 19, 2023 Sell
SANDEEP PRAKASHCHANDRA JAIN (HUF)
  • Qty 70919
  • Average Price ₹175.42
Jan 19, 2023 PURCHASE
SANDEEP PRAKASHCHANDRA JAIN (HUF)
  • Qty 43919
  • Average Price ₹175.01
Nov 12, 2021 PURCHASE
ALPHA LEON ENTERPRISES LLP
  • Qty 91576
  • Average Price ₹214.60
Nov 12, 2021 Sell
ALPHA LEON ENTERPRISES LLP
  • Qty 54022
  • Average Price ₹215.32
Sep 20, 2021 PURCHASE
MAULIK CONSULTANCY
  • Qty 36000
  • Average Price ₹156.80
Sep 20, 2021 Sell
MAULIK CONSULTANCY
  • Qty 88000
  • Average Price ₹157.50
Sep 15, 2021 Sell
MAHESH R KANZARIYA
  • Qty 100000
  • Average Price ₹126.08
Sep 15, 2021 Sell
PARTH G DESAI
  • Qty 64000
  • Average Price ₹126.73
Sep 15, 2021 Sell
YOGESH DULABHAI MIYANI
  • Qty 80000
  • Average Price ₹126.00
Apr 22, 2021 Sell
NIRAG J SHAH
  • Qty 32000
  • Average Price ₹125.22
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Par Drugs & Chemicals Ltd share price previously?
Par Drugs & Chemicals Ltd share price was down by -1.11% from the previous closing price of ₹98.84.
Who are peers of Par Drugs & Chemicals Ltd?
The peers of Par Drugs & Chemicals Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Mankind Pharma Ltd, Lupin Ltd.
Who is/are the promoter/promoters of Par Drugs & Chemicals Ltd?
The promotor/promotors of Par Drugs & Chemicals Ltd are FALGUN VALLABHBHAI SAVANI, JIGNESHBHAI VALLABHBHAI SAVANI, GHANSHAYAMBHAI BHAGVANBHAI SAVANI, Nayna Jignesh Savani, Krishna Mitulbhai Shah, Kajal Chintanbhai Vaghani, Pravin Manjibhai Bhayani, Bintal Bhaveshkumar Shah.
What has been 52-week high of Par Drugs & Chemicals Ltd stocks?
The highest price of Par Drugs & Chemicals Ltd stock is ₹348.45 in the last 52-week.
What is the share price of Par Drugs & Chemicals Ltd (PAR) today on NSE?
As on Mar 13, 2025, Par Drugs & Chemicals Ltd (PAR)’s share price on NSE is Rs 97.74
What is the market cap of Par Drugs & Chemicals Ltd (PAR?)
The current market capitalisation of Par Drugs & Chemicals Ltd (PAR) is 120.27 crores
What is Par Drugs & Chemicals Ltd Share symbol?
The symbol of Par Drugs & Chemicals Ltd is PAR.
What is the PE ratio of Par Drugs & Chemicals Ltd (PAR)?
The current PE ratio of Par Drugs & Chemicals Ltd (PAR) is 7.79.
What is the PB ratio of Par Drugs & Chemicals Ltd (PAR)?
The current PB ratio of Par Drugs & Chemicals Ltd (PAR) is 1.24.
Today’s High & Low share prices of Par Drugs & Chemicals Ltd (PAR) on NSE?
Today, the share price of Par Drugs & Chemicals Ltd (PAR) on NSE touched a high of Rs 102.7 and a low of Rs 96.05
What price did Par Drugs & Chemicals Ltd (PAR) shares open on the NSE today?
On NSE, the share price of Par Drugs & Chemicals Ltd (PAR) opened at Rs 96.05
What is the 52-week high of Par Drugs & Chemicals Ltd (PAR)?
The 52-week high price of Par Drugs & Chemicals Ltd (PAR) is Rs 348.45
What is the 52-week low of Par Drugs & Chemicals Ltd (PAR) ?
The 52-week low price of Par Drugs & Chemicals Ltd (PAR) is Rs 89.7

ABOUT PAR DRUGS & CHE.

Par Drugs & Chemicals Ltd, incorporated in the year 1999, has its registered office in 805 Dwarkesh Complex, RC Dutt Road Alkapuri, Vadodara, Gujarat, 390007, 91-265-2332018. The main industry in which Par Drugs & Chemicals Ltd operates is Pharmaceuticals - Indian - Bulk Drugs.

Auditor/Auditors for Par Drugs & Chemicals Ltd is/are Sarupria Somani & Associates. In the main management, FALGUN VALLABHBHAI SAVANI is chairman and is the company secretary for Par Drugs & Chemicals Ltd.

  • FVS FALGUN VALLABHBHAI SAVANI Chairman / Executive Director
  • JVS JIGNESHBHAI VALLABHBHAI SAVANI Executive Director & CEO
  • GBS GHANSHAYAMBHAI BHAGVANBHAI SAVANI WTD & Executive Director
  • NJS Nayna Jignesh Savani Non Executive Director
  • KMS Krishna Mitulbhai Shah Independent Non Exe. Director
  • KCV Kajal Chintanbhai Vaghani Independent Non Exe. Director
  • PMB Pravin Manjibhai Bhayani Independent Non Exe. Director
  • BBS Bintal Bhaveshkumar Shah Independent Non Exe. Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement